indazoles has been researched along with deoxyguanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aishima, S; Kaneki, M; Kitajima, Y; Nakamura, J; Noshiro, H; Tanaka, T; Wakiyama, K; Yanagihara, K | 1 |
| Jena, NR; Shah, PK; Shukla, PK | 1 |
2 other study(ies) available for indazoles and deoxyguanosine
| Article | Year |
|---|---|
Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetyl Coenzyme A; Anaerobiosis; Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Deoxyguanosine; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Insulin; Mice; Nitroimidazoles; Oxidative Phosphorylation; Stomach Neoplasms; Tumor Hypoxia; Xenograft Model Antitumor Assays | 2017 |
Reactions of Ru(III)-drugs KP1019 and KP418 with guanine, 2'-deoxyguanosine and guanosine: a DFT study.
Topics: Antineoplastic Agents; Deoxyguanosine; DNA; Guanine; Guanosine; Indazoles; Organometallic Compounds; RNA; Ruthenium; Ruthenium Compounds | 2022 |